
October 06, 2024
Description
The securities of White Cliff Minerals Limited (‘WCN’) will be placed in trading halt at the request of WCN, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Wednesday, 9 October 2024 or when the announcement is released to the market.
Issued by
ASX Compliance
Click here for the full ASX Release
This article includes content from White Cliff Minerals Limited, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.
The Conversation (0)
11 November
China Grants Conditional Approval to Codelco-SQM Lithium Joint Venture
Chile’s state-owned copper giant Corporación Nacional del Cobre de Chile (Codelco) and local lithium producer Sociedad Quimica y Minera (SQM) (NYSE:SQM) have cleared the final major hurdle for a long-planned partnership after China’s antitrust regulator granted conditional approval to the... Keep Reading...
10 November
Laguna Verde Resource Increase Based on Recent Licence Acquisition
CleanTech Lithium PLC ("CleanTech Lithium" or "CleanTech" or the "Company") (AIM: CTL, Frankfurt:T2N), an exploration and development company advancing sustainable lithium projects in Chile, announces an updated resource estimate for its Laguna Verde project following the recent acquisition of... Keep Reading...
05 November
Top 5 Canadian Lithium Stocks of 2025
The global lithium market saw sharp swings in Q3 2025 as shifting supply dynamics, policy uncertainty, and geopolitical developments reshaped investor sentiment. After hitting a four-year low in June, benchmark lithium carbonate prices briefly surged to an 11 month high in August on speculation... Keep Reading...
Latest News
Latest Press Releases
Related News
TOP STOCKS
American Battery4.030.24
Aion Therapeutic0.10-0.01
Cybin Corp2.140.00





